These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 8734682)
1. Stability of granisetron hydrochloride with dexamethasone sodium phosphate for 14 days. Chin A; Moon YS; Chung KC; Gill MA Am J Health Syst Pharm; 1996 May; 53(10):1174-6. PubMed ID: 8734682 [No Abstract] [Full Text] [Related]
2. Stability and compatibility of granisetron hydrochloride in i.v. solutions and oral liquids and during simulated Y-site injection with selected drugs. Mayron D; Gennaro AR Am J Health Syst Pharm; 1996 Feb; 53(3):294-304. PubMed ID: 8808027 [TBL] [Abstract][Full Text] [Related]
3. Stability of granisetron hydrochloride in polypropylene syringes. Quercia RA; Zhang J; Fan C; Chow MS Am J Health Syst Pharm; 1996 Nov; 53(22):2744-6. PubMed ID: 8931820 [No Abstract] [Full Text] [Related]
4. Stability of granisetron hydrochloride in a disposable elastomeric infusion device. Chung KC; Chin A; Gill MA Am J Health Syst Pharm; 1995 Jul; 52(14):1541-3. PubMed ID: 7552896 [TBL] [Abstract][Full Text] [Related]
5. Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride. Wu G; Powers D; Yeung S; Chen F; Neelon K Int J Pharm Compd; 2018; 22(1):86-94. PubMed ID: 29385389 [TBL] [Abstract][Full Text] [Related]
6. Stability of i.v. admixture containing metoclopramide, diphenhydramine hydrochloride, and dexamethasone sodium phosphate in 0.9% sodium chloride injection. Kintzel PE; Zhao T; Wen B; Sun D Am J Health Syst Pharm; 2014 Dec; 71(23):2061-5. PubMed ID: 25404598 [TBL] [Abstract][Full Text] [Related]
7. Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate. Wu G; Yeung S; Chen F Int J Pharm Compd; 2017; 21(1):66-75. PubMed ID: 28346199 [TBL] [Abstract][Full Text] [Related]
8. Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in infusion bags and syringes for 32 days. Hagan RL; Mallett MS; Fox JL Am J Health Syst Pharm; 1996 Jun; 53(12):1431-5. PubMed ID: 8781690 [No Abstract] [Full Text] [Related]
9. Compatibility and stability of granisetron, dexamethasone, and methylprednisolone in injectable solutions. Pinguet F; Rouanet P; Martel P; Fabbro M; Salabert D; Astre C J Pharm Sci; 1995 Feb; 84(2):267-8. PubMed ID: 7738814 [No Abstract] [Full Text] [Related]
10. Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in 0.9% sodium chloride injection and in 5% dextrose injection. Evrard B; Ceccato A; Gaspard O; Delattre L; Delporte JP Am J Health Syst Pharm; 1997 May; 54(9):1065-8. PubMed ID: 9143656 [No Abstract] [Full Text] [Related]
11. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Trissel LA; Gilbert DL; Martinez JF Am J Health Syst Pharm; 1997 Jan; 54(1):56-60. PubMed ID: 9117791 [TBL] [Abstract][Full Text] [Related]
12. Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection. Wu G; Powers D; Yeung S; Chen F Int J Pharm Compd; 2018; 22(1):76-85. PubMed ID: 29385388 [TBL] [Abstract][Full Text] [Related]
13. Stability of ondansetron and dexamethasone infusion upon refrigeration. Rolin C; Hecq JD; Vanbeckbergen DF; Jamart J; Galanti LM Ann Pharmacother; 2011 Jan; 45(1):130-1. PubMed ID: 21156815 [No Abstract] [Full Text] [Related]
14. Stability of granisetron hydrochloride in an extemporaneously prepared oral liquid. Quercia RA; Zhang J; Fan C; Chow MS Am J Health Syst Pharm; 1997 Jun; 54(12):1404-6. PubMed ID: 9194985 [TBL] [Abstract][Full Text] [Related]
15. Compatibility of granisetron hydrochloride with selected alkaline drugs. Trissel LA; Martinez JF Am J Health Syst Pharm; 1995 Jan; 52(2):208. PubMed ID: 12879553 [No Abstract] [Full Text] [Related]
16. Thermal and non-thermal methods to evaluate compatibility of granisetron hydrochloride with tablet excipients. Late SG; Banga AK Pharmazie; 2008 Jun; 63(6):453-8. PubMed ID: 18604989 [TBL] [Abstract][Full Text] [Related]
17. Stability of dexamethasone sodium phosphate, diphenhydramine hydrochloride, lorazepam, and metoclopramide hydrochloride in portable infusion-pump reservoirs. Stiles ML; Allen LV; Prince SJ; Holland JS Am J Hosp Pharm; 1994 Feb; 51(4):514-7. PubMed ID: 8017420 [No Abstract] [Full Text] [Related]
18. Compatibility and stability of dexamethasone sodium phosphate and ketamine hydrochloride subcutaneous infusions in polypropylene syringes. Watson DG; Lin M; Morton A; Cable CG; McArthur DA J Pain Symptom Manage; 2005 Jul; 30(1):80-6. PubMed ID: 16043011 [TBL] [Abstract][Full Text] [Related]
19. Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids. Sun S; Schaller J; Placek J; Duersch B Cancer Chemother Pharmacol; 2013 Sep; 72(3):509-13. PubMed ID: 23860958 [TBL] [Abstract][Full Text] [Related]
20. Stability of diluted dexamethasone sodium phosphate injection at two temperatures. Lugo RA; Nahata MC Ann Pharmacother; 1994 Sep; 28(9):1018-9. PubMed ID: 7803873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]